Mirum Pharmaceuticals Inc (NASDAQ: MIRM) is 47.25% higher on its value in year-to-date trading and has touched a low of $33.51 and a high of $54.23 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MIRM stock was last observed hovering at around $49.09 in the last trading session, with the day’s gains setting it 1.21%.
Currently trading at $50.3, the stock is 1.79% and 9.37% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.22 million and changing 2.46% at the moment leaves the stock 13.88% off its SMA200. MIRM registered 21.64% gain for a year compared to 6-month gain of 22.15%.
The stock witnessed a 11.06% loss in the last 1 month and extending the period to 3 months gives it a 11.78%, and is -0.51% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.98% over the week and 3.24% over the month.
Mirum Pharmaceuticals Inc (MIRM) has around 322 employees, a market worth around $2.49B and $379.25M in sales. Profit margin for the company is -20.39%. Distance from 52-week low is 50.08% and -7.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.09%).
The EPS is expected to grow by 39.83% this year
The shares outstanding are 49.45M, and float is at 40.03M with Short Float at 15.53%.
The top institutional shareholder in the company is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. with over 6.5 million shares valued at $222.08 million. The investor’s holdings represent 13.7512 of the MIRM Shares outstanding. As of 2024-06-30, the second largest holder is JANUS HENDERSON GROUP PLC with 4.99 million shares valued at $170.56 million to account for 10.5615 of the shares outstanding. The other top investors are BVF INC/IL which holds 4.37 million shares representing 9.2516 and valued at over $149.41 million, while EVENTIDE ASSET MANAGEMENT, LLC holds 7.6528 of the shares totaling 3.61 million with a market value of $123.59 million.
Mirum Pharmaceuticals Inc (MIRM) Insider Activity
The most recent transaction is an insider sale by Howe Jolanda, the company’s SVP, GLOBAL CONTROLLER. SEC filings show that Howe Jolanda sold 564 shares of the company’s common stock on Jul 02 ’25 at a price of $48.25 per share for a total of $27213.0. Following the sale, the insider now owns 2903.0 shares.
Mirum Pharmaceuticals Inc disclosed in a document filed with the SEC on Jul 03 ’25 that Howe Jolanda (SVP, GLOBAL CONTROLLER) sold a total of 477 shares of the company’s common stock. The trade occurred on Jul 03 ’25 and was made at $49.08 per share for $23411.0. Following the transaction, the insider now directly holds 2426.0 shares of the MIRM stock.
